Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Thrombotic microangiopathy associated with use of interferon-beta.
Interferon in relapsing-remitting multiple sclerosis.
Raxone®/Catena® (idebenone)
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.
Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse-Remitting Multiple Sclerosis
Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership.
Complex antibody profiling to predict clinical outcome in childhood ADS.
Rituximab product approval information - Licensing action
Once-daily AUBAGIO® delayed onset of clinically definite multiple sclerosis (MS) in TOPIC study
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Society for Neuroscience Annual Meeting
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
NICE recommends new treatment option for multiple sclerosis (Dimethyl fumarate)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Ethnicity and prevalence of multiple sclerosis in east London.
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Dilantin
Adaptive myelination from fish to man.

Pages